Integrative Skin Science and Research - Location 2

Sacramento, California 95815

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema, Obesity, Psoriasis

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight — Completed